Didier Trono, Priscilla Turelli, Marc Emmenegger
The clinical outcome of SARS-CoV-2 infections, which can range from asymptomatic to lethal, is crucially shaped by the concentration of antiviral antibodies and by their affinity to their targets. However, the affinity of polyclonal antibody responses in p ...
LIFE SCIENCE ALLIANCE LLC2022